FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Terbinafine (Lamisil) Oral Granules
Status: Discontinuation
»Therapeutic Categories: Dermatology

Expand all

Novartis (New 05/24/2016)

Company Contact Information:
888-669-6682

Presentation Posting Date Related Information
125 mg (pack of 3 cartons each containing 14 packets (42 packets)) (NDC 0078-0499-59) 05/24/2016 Discontinuation of the product is not due to manufacturing, product quality, safety or efficacy concerns.
187.5 mg (pack of 3 cartons each containing 14 packets (42 packets)) (NDC 0078-0500-59) 05/24/2016 Discontinuation of the product is not due to manufacturing, product quality, safety or efficacy concerns.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English